Skip to main content
. 2022 Jul 25;12:885236. doi: 10.3389/fonc.2022.885236

Figure 4.

Figure 4

CD3 immunostaining and expression scores in OSCCs. (A): Shown are images of no [0], low [1+], moderate [2+], and strong [3+] CD3 expression scores. (B, C): Shown are Kaplan-Meier estimates of the overall survival (B) and progression free survival (C) of CD3+ (2+ and 3+) and CD3- (0 and 1+) patients. HR, hazard ratio; CI: 95% confidence interval.